Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004357:Drug Synergism; D004423:Ear / Q000187:drug effects; D004558:Electric Stimulation; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010525:Peripheral Nerves / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012669:Seminal Vesicles / Q000187:drug effects; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects*
D000959:Antihypertensive Agents; D007093:Imidazoles; D012110:Reserpine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine